First Amendment: BCD rolled back from 150% to 10% for bona fide research. Second Amendment: trading SKUs reclassified, eliminating ambiguity between commercial and laboratory-grade chemicals.
Reversed a fifteenfold BCD escalation on India's research infrastructure. Established a classification distinction between commercial trading and laboratory-grade chemicals that did not previously exist.